TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 6 | 0 | 4 | -2 | -18 | -25 | -19 | -10 |
| S | %wins | 67 | 50 | 67 | 100 | 83 | 83 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/14/14 16:31 | 2/12/14 | MDGN | Medgenics, Inc. | NY | Health | BioPrd | Biological Products, (No Diag | Pearlman Andrew | PA | D | S.d | -101 | 9.00 | 1 | -11 | -21 | 42 | D | 57 | 81 | 107 | 32 | 36 | 26 | 7 | 4 | -1 | -2 | -15 | -22 | -27 | -20 | |
2/6/14 18:02 | 2/4/14 | MDGN | Medgenics, Inc. | NY | Health | BioPrd | Biological Products, (No Diag | Pearlman Andrew | PA | D | S.d | -160 | 8.00 | 1 | -20 | -32 | 42 | D | 135 | 26 | 92 | 17 | 41 | 23 | 24 | 8 | 0 | 6 | -3 | -25 | -16 | -8 | |
1/31/14 18:29 | 1/29/14 | MDGN | Medgenics, Inc. | NY | Health | BioPrd | Biological Products, (No Diag | Pearlman Andrew | PA | D | S.dm | -188 | 7.50 | 1 | -25 | -37 | 42 | D | 158 | 27 | 75 | 11 | 43 | 17 | 18 | 20 | 6 | 10 | 10 | -12 | -7 | 9 | |
1/10/14 17:30 | 1/8/14 | MDGN | Medgenics, Inc. | NY | Health | BioPrd | Biological Products, (No Diag | Pearlman Andrew | PA | D | S.dm | -528 | 6.60 | 0 | -80 | -65 | 42 | D | 138 | -4 | 70 | 15 | 6 | 19 | 12 | -2 | -6 | 0 | 23 | -7 | 5 | -9 | |
9/19/12 16:01 | 9/17/12 | MDGN | Medgenics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Pearlman Andrew | CA | DO | P,CEO | S.m | -113 | 10.27 | 1 | -11 | -24 | 35 | D | 167 | 114 | 55 | -7 | -17 | -6 | -2 | -2 | 0 | -16 | -20 | -57 | -38 | |
9/17/12 16:02 | 9/13/12 | MDGN | Medgenics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Pearlman Andrew | CA | DO | P,CEO | S.m | -252 | 10.67 | 1 | -24 | -34 | 46 | D | 196 | 118 | 48 | -6 | -18 | -5 | 2 | 5 | 11 | -8 | -20 | -48 | -45 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |